M.ToddJ
In the WASID trial (Warfarin-Aspirin Symptomatic Intracranial Disease), warfarin (target INR, 23) compared with aspirin 650 mg twice a day was found to have a higher rate of major hemorrhages (relative difference, 5.1%) and all-cause death (relative difference, 5.4%) but did not prevent more primary end points (stroke, ICH, vascular death) (22% in both arms at a mean follow-up of 1.8 years) or ischemic strokes in the territory of the stenotic artery (2-year rate: 15% for aspirin versus 13% for warfarin)
Any prescribing would be unlicensed and may occasionally occur through specialist weight management services via special order or private prescription
Daily totals: 104 grams protein, 32 grams fiber, 1,230 calories
After incubation with the primary antibody, the cells were washed with PBST and stained with secondary antibodies (Goat Anti-Rabbit IgG H&L Alexa Fluor 488, Abcam, ab150077